Related references
Note: Only part of the references are listed.Medical conditions affecting sports participation
Stephen G. Rice
PEDIATRICS (2008)
Rationale and design of a randomized clinical trial of β-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome
Ronald V. Lacro et al.
AMERICAN HEART JOURNAL (2007)
Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome
JP Habashi et al.
SCIENCE (2006)
Surgical treatment for scoliosis in Marfan syndrome
M Di Silvestre et al.
SPINE (2005)
Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases
BJ Maron et al.
CIRCULATION (2004)
Role of computed tomography and magnetic resonance imaging in assessment of acute aortic syndromes
KJ Macura et al.
SEMINARS IN ULTRASOUND CT AND MRI (2003)
Update of the UMD-FBN1 mutation database and creation of an FBN1 polymorphlism database
G Collod-Beroud et al.
HUMAN MUTATION (2003)
Share Paper
